Table 1. Association between GOLPH3 expression and the clinicopathologic characteristics of 137 patients treated with radical cystectomy for urothelial carcinoma of the bladder.
| Characteristic | Total cases | GOLPH3 expression | P value | |
|---|---|---|---|---|
| Low | High | |||
| Total | 137 | 72 | 65 | |
| Gender | 0.783 | |||
| Female | 24(17.5%) | 12(16.7%) | 12(18.5%) | |
| Male | 113(82.5%) | 60(83.3%) | 53(81.5%) | |
| Age | 0.031 | |||
| ≤ 65 y | 66(48.2%) | 41(56.9%) | 25(38.5%) | |
| < 65 y | 71(51.8%) | 31(43.1%) | 40(61.5%) | |
| Grade | 0.067 | |||
| G1–G2 | 42(30.7%) | 27(37.5%) | 15(23.1%) | |
| G3 | 95(69.3%) | 45(62.5%) | 50(76.9%) | |
| pT status | 0.145 | |||
| NMI | 68(49.6%) | 40(55.6%) | 28(43.1%) | |
| MI | 69(50.4%) | 32(44.4%) | 37(56.9%) | |
| pN status | 0.315 | |||
| N0 | 120(87.6%) | 65(90.3%) | 55(84.6%) | |
| N1–N2 | 17(12.4%) | 7(9.7%) | 10(15.4%) | |
| Multiplicity | 0.877 | |||
| Unifocal | 102(74.5%) | 54(75.0%) | 48(73.8%) | |
| Multifocal | 35(25.5%) | 18(25.0%) | 17(26.2%) | |
NMI = Non-muscle invasive bladder cancer; MI = Muscle invasive bladder cancer.